Quarterly report pursuant to Section 13 or 15(d)

Inventories (Tables)

v3.21.4
Inventories (Tables)
6 Months Ended
Nov. 30, 2021
Inventory Disclosure [Abstract]  
Schedule of Inventory, Current

(in thousands)

    

November 30, 2021

    

May 31, 2021

Raw materials

$

22,536

$

28,085

Work-in-progress

 

66,021

 

65,394

Total

$

88,557

$

93,479

Schedule of remaining shelf life of inventory

Expiration period ending November 30,

    

Remaining shelf-life

    

Raw materials

    

Work-in-progress bulk drug product

    

Work-in-progress finished drug product in vials

    

Total inventories

2022

0 to 12 months

$

21,014

$

-

$

-

$

21,014

2023

13 to 24 months

1,078

-

-

1,078

2024

25 to 36 months

1,902

-

29,143

31,045

2025

37 to 48 months

192

-

24,315

24,507

2026

49 to 60 months

695

-

-

695

Thereafter

61 or more months

157

12,563

-

12,720

Total inventories

25,038

12,563

53,458

91,059

Inventories reserved

(2,502)

-

-

(2,502)

Total inventories, net

$

22,536

$

12,563

$

53,458

$

88,557